در حال جستجو در محتوی

ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده: 4 مورد
Cervical adenocarcinoma in situ
Cervical cancer in pregnancy
Cervical cancer screening tests: Techniques for cervical cytology and human papillomavirus testing
Cervical cancer screening tests: Visual inspection methods
Cervical cancer screening: Risk assessment, evaluation, and management after screening
Cervical cancer screening: The cytology and human papillomavirus report
Cervical cytology: Evaluation of atypical and malignant glandular cells
Cervical intraepithelial neoplasia: Ablative therapies
Cervical intraepithelial neoplasia: Choosing excision versus ablation, and prognosis and follow-up after treatment
Cervical intraepithelial neoplasia: Diagnostic excisional procedures
Cervical intraepithelial neoplasia: Management
Cervical intraepithelial neoplasia: Terminology, incidence, pathogenesis, and prevention
Fertility-sparing surgery for cervical cancer
Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis
Invasive cervical cancer: Patterns of recurrence and post-treatment surveillance
Invasive cervical cancer: Staging and evaluation of lymph nodes
Management of early-stage cervical cancer
Management of locally advanced cervical cancer
Management of recurrent or metastatic cervical cancer
Overview of approach to cervical cancer survivors
Pelvic and paraaortic lymphadenectomy in gynecologic cancers
Preinvasive and invasive cervical neoplasia in patients with HIV infection
Reproductive effects of cervical excisional and ablative procedures
Screening for cervical cancer in patients with HIV infection and other immunocompromised states
Screening for cervical cancer in resource-limited settings
Screening for cervical cancer in resource-rich settings
Small cell neuroendocrine carcinoma of the cervix
Virology of human papillomavirus infections and the link to cancer
Approach to survivors of epithelial ovarian, fallopian tube, or peritoneal carcinoma
Opportunistic salpingectomy for ovarian, fallopian tube, and peritoneal carcinoma risk reduction
Risk-reducing salpingo-oophorectomy in patients at high risk of epithelial ovarian and fallopian tube cancer
Cervical cancer screening: The cytology and human papillomavirus report
Exenteration for gynecologic cancer
Management of menorrhagia during chemotherapy
Office-based endometrial sampling procedures
Pelvic and paraaortic lymphadenectomy in gynecologic cancers
The approach to ovarian cancer in older women
Treatment-related toxicity from the use of radiation therapy for gynecologic malignancies
Gestational trophoblastic disease: Pathology and genetics
Human chorionic gonadotropin: Biochemistry and measurement in pregnancy and disease
Hydatidiform mole: Epidemiology, clinical features, and diagnosis
Hydatidiform mole: Treatment and follow-up
Initial management of high-risk gestational trophoblastic neoplasia
Initial management of low-risk gestational trophoblastic neoplasia
Management of resistant or recurrent gestational trophoblastic neoplasia
Adjuvant therapy of early-stage (stage I and II) epithelial ovarian, fallopian tube, or peritoneal cancer
Adnexal mass: Differential diagnosis
Adnexal mass: Evaluation and management in pregnancy
Adnexal mass: Role of serum biomarkers in diagnosing epithelial carcinoma of the ovary, fallopian tube, or peritoneum
Adnexal mass: Ultrasound categorization
Approach to survivors of epithelial ovarian, fallopian tube, or peritoneal carcinoma
Approach to the patient with an adnexal mass
Borderline ovarian tumors
Cancer of the ovary, fallopian tube, and peritoneum: Surgical cytoreduction
Cancer of the ovary, fallopian tube, and peritoneum: Surgical options for recurrent cancer
Chemotherapy of ovarian cancer in pregnancy
Early detection of epithelial ovarian cancer: Role of symptom recognition
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Histopathology
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Incidence and risk factors
Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Surgical staging
First-line chemotherapy for advanced (stage III or IV) epithelial ovarian, fallopian tube, and peritoneal cancer
Intraperitoneal chemotherapy for treatment of ovarian cancer
Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and prevention of endometrial and ovarian cancer
Malignancy-related ascites
Management of low-grade, serous carcinomas of the ovary
Management of ovarian cancer associated with BRCA and other genetic mutations
Medical treatment for relapsed epithelial ovarian, fallopian tube, or peritoneal cancer: Platinum-resistant disease
Medical treatment for relapsed epithelial ovarian, fallopian tube, or peritoneal cancer: Platinum-sensitive disease
Opportunistic salpingectomy for ovarian, fallopian tube, and peritoneal carcinoma risk reduction
Ovarian germ cell tumors: Pathology, epidemiology, clinical manifestations, and diagnosis
Overview of epithelial carcinoma of the ovary, fallopian tube, and peritoneum
Patient selection and approach to neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer
Risk-reducing salpingo-oophorectomy in patients at high risk of epithelial ovarian and fallopian tube cancer
Screening for ovarian cancer
Sex cord-stromal tumors of the ovary: Epidemiology, clinical features, and diagnosis in adults
Sex cord-stromal tumors of the ovary: Management in adults
Struma ovarii
Treatment of malignant germ cell tumors of the ovary
Adjuvant treatment of high-risk endometrial cancers
Adjuvant treatment of intermediate-risk endometrial cancer
Clinical features, diagnosis, staging, and treatment of uterine carcinosarcoma
Endometrial cancer: Pathology and classification
Endometrial carcinoma: Clinical features, diagnosis, prognosis, and screening
Endometrial carcinoma: Epidemiology, risk factors, and prevention
Endometrial carcinoma: Serous and clear cell histologies
Endometrial carcinoma: Staging and surgical treatment
Endometrial hyperplasia or endometrial intraepithelial neoplasia: Clinical features, diagnosis, and differential diagnosis
Endometrial hyperplasia or endometrial intraepithelial neoplasia: Management and prognosis
Endometrial stromal sarcomas, related tumors, and uterine adenosarcoma
Fertility preservation in patients with endometrial carcinoma
Gestational trophoblastic neoplasia: Epidemiology, clinical features, diagnosis, staging, and risk stratification
Initial treatment of metastatic endometrial cancer
Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and prevention of endometrial and ovarian cancer
Management of locoregional recurrence of endometrial cancer
Overview of approach to endometrial cancer survivors
Overview of resectable endometrial carcinoma
Overview of the evaluation of the endometrium for malignant or premalignant disease
Pelvic and paraaortic lymphadenectomy in gynecologic cancers
Subsequent line systemic therapy for metastatic endometrial cancer
Treatment and prognosis of uterine leiomyosarcoma
Treatment of low-risk endometrial cancer
Uterine fibroids (leiomyomas): Variants and smooth muscle tumors of uncertain malignant potential
Uterine sarcoma: Classification, epidemiology, clinical manifestations, and diagnosis
Vaginal cancer
Vaginal intraepithelial neoplasia
Squamous cell carcinoma of the vulva: Medical therapy and prognosis
Squamous cell carcinoma of the vulva: Staging and surgical treatment
Vulvar and vaginal intraepithelial neoplasia in patients with HIV infection
Vulvar cancer: Epidemiology, diagnosis, histopathology, and treatment
Vulvar squamous intraepithelial lesions (vulvar intraepithelial neoplasia)
Vulvar wide local excision and simple vulvectomy